Larimar Therapeutics Inc. (LRMR)
3.32
0.03 (0.91%)
At close: Jan 15, 2025, 11:40 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -36.95M | -35.35M | -50.64M | -42.48M | -23.13M | -61.37M | -52.03M | -57.88M | -74.29M | -36.48M | -14.03M | -13.88M | -13.16M |
| Depreciation & Amortization | 311.00K | 318.00K | 326.00K | 155.00K | 78.00K | 261.00K | 188.00K | 212.00K | 70.00K | 16.00K | 12.00K | 11.00K | 4.00K |
| Stock-Based Compensation | 7.62M | 6.62M | 5.47M | 2.16M | 129.00K | 173.00K | n/a | n/a | 8.58M | 1.55M | n/a | n/a | n/a |
| Other Working Capital | -2.11M | 1.64M | 3.72M | 1.25M | -2.40M | 827.00K | 454.00K | -6.47M | 7.74M | -815.00K | -397.00K | 692.00K | 801.00K |
| Other Non-Cash Items | -1.93M | -820.00K | -15.00K | 10.00K | -3.63M | 9.78M | 9.08M | 10.64M | 9.09M | 6.67M | 645.00K | 218.00K | 78.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 3.63M | -9.63M | n/a | n/a | -8.58M | -815.00K | n/a | n/a | n/a |
| Change in Working Capital | -2.51M | 1.67M | 2.75M | -2.04M | 226.00K | 593.00K | -99.00K | -5.50M | 6.73M | 815.00K | -1.63M | 62.00K | 801.00K |
| Operating Cash Flow | -33.46M | -27.57M | -42.10M | -42.20M | -22.70M | -51.49M | -43.78M | -51.98M | -59.55M | -28.24M | -15.00M | -13.59M | -12.27M |
| Capital Expenditures | -164.00K | -100.00K | -333.00K | -62.00K | -83.00K | -108.00K | -55.00K | -660.00K | -595.00K | -58.00K | -17.00K | -2.00K | -35.00K |
| Acquisitions | -33.52K | 90.86K | -24.50K | -1.30M | -26.03M | 6.76M | n/a | n/a | 91.50M | n/a | n/a | n/a | 2.00K |
| Purchase of Investments | -101.23M | -133.61M | -8.25M | -24.49M | -82.86M | -117.15M | -114.51M | -136.53M | -287.49M | -57.20M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 134.75M | 42.75M | 32.75M | 1.00M | 109.47M | 110.39M | 150.21M | 188.60M | 195.99M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 33.52K | -90.86K | 24.50K | 41.93M | -583.00K | -6.76M | 35.70M | 35.00K | -19.00K | -57.00K | n/a | n/a | -12.00K |
| Investing Cash Flow | 33.35M | -90.96M | 24.17M | 17.09M | -83.00K | -6.87M | 35.65M | 51.45M | -92.12M | -57.31M | -17.00K | -2.00K | -45.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 16.37M | -2.94M | -1.38M | 7.34M | n/a | 5.99M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 67.22M | 195.00K | 220.00K | 131.02M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 30.00K | n/a | n/a | 18.00M | 19.39M | n/a | n/a | n/a | n/a | n/a | n/a | 13.00K | n/a |
| Financial Cash Flow | 30.00K | 75.26M | 19.89M | 93.59M | 19.39M | 66.91M | 16.56M | -2.71M | 129.16M | 108.14M | 40.60M | 22.06M | 10.07M |
| Net Cash Flow | -76.00K | -43.27M | 1.95M | 68.48M | -3.39M | 8.55M | 8.43M | -3.24M | -22.51M | 22.59M | n/a | n/a | n/a |
| Free Cash Flow | -33.62M | -27.67M | -42.44M | -42.26M | -22.78M | -51.59M | -43.84M | -52.63M | -60.15M | -28.30M | -15.02M | -13.59M | -12.31M |